Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TAAR1 | Q96RJ0 | 1/20 | 0.39 |
| ▸ | PPARG | P37231 | 1/20 | 0.33 |
| ▸ | PPARA | Q07869 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.32 |
| ▸ | MEN1 | O00255 | 2/20 | 0.32 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.32 |
| ▸ | P2RX4 | Q99571 | 1/20 | 0.32 |
| ▸ | MAOA | P21397 | 1/20 | 0.32 |
| ▸ | MAOB | P27338 | 1/20 | 0.32 |
| ▸ | CASR | P41180 | 1/20 | 0.31 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.31 |
| ▸ | MAPT | P10636 | 2/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | GPR52 | Q9Y2T5 | 1/20 | 0.31 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.31 |
| ▸ | GAA | P10253 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23678435 | 0.94 | PPARG (0.36) | TAAR1PPARGPPARAKMT2AMEN1 | |
| SCHEMBL23678280 | 0.89 | GAA (0.39) | PPARGPPARAKMT2AMEN1GAA | |
| SCHEMBL23678157 | 0.85 | KDM4E (0.31) | ALDH1A1MAPTKDM4EGAA | |
| SCHEMBL23678256 | 0.84 | LMNA (0.37) | KMT2AMAOAMAOBMAPTKDM4E | |
| SCHEMBL23678451 | 0.83 | CYP1A2 (0.33) | KMT2AMEN1ALDH1A1GAA | |
| SCHEMBL24199453 | 0.82 | LMNA (0.34) | KMT2AALDH1A1TSHR | |
| SCHEMBL23678448 | 0.82 | LMNA (0.34) | KMT2AALDH1A1TSHR | |
| SCHEMBL23678303 | 0.82 | HSD17B10 (0.36) | ALDH1A1MAOAMAOBMAPTKDM4E | |
| SCHEMBL23678141 | 0.81 | MEN1 (0.33) | KMT2AMEN1NFE2L2 | |
| SCHEMBL24199550 | 0.80 | MEN1 (0.33) | KMT2AMEN1ALDH1A1NFE2L2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | SUMITOMO CHEMICAL COMPANY, LIMITED (JP) | 2022-01-18 | — | — | US | disclosed |
| EP-3544973-B1 | TETRAZOLINONE COMPOUNDS AND ITS USE AS PEST CONTROL AGENTS | SUMITOMO CHEMICAL CO (JP) | 2021-07-28 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11225470-B2 | Tetrazolinone compounds and its use as pest control agents | CYC1, MT-CO1, CTRL | TAAR1 36/4885PPARG 1367/4885PPARA 2579/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.